DGAP-News

Sangui BioTech International Inc. Sangui BioTech International officially approved as trading on OTCQB

DGAP-News: Sangui BioTech International Inc. / Key word(s): Regulatory
Approval
Sangui BioTech International Inc. Sangui BioTech International
officially approved as trading on OTCQB

06.11.2014 / 12:00

---------------------------------------------------------------------

Sangui BioTech International officially approved as trading on OTCQB

Witten, Germany, November 6, 2014 - OTC Markets Group has officially
informed Sangui Biotech International, Inc., that the application of the
company for continued trading on the OTCQB venture market place for early
stage and developing companies was approved of today. Subsequent to the
reorganization of the OTC markets, resulting in higher transparency levels
and significantly improved services for issuers and investors in particular
on OTCQB, Sangui has submitted all the mandatory documents and successfully
met all of the initial requirements.

Sangui BioTech henceforth trades on the OTCQB venture stage marketplace for
early stage and developing U.S. and international companies (OTCQB:SGBI).
Companies are current in their reporting and undergo an annual verification
and management certification process. Investors can find real-time quotes
and market information for the company on www.otcmarkets.com.

Sangui BioTech International, Inc. ("SGBI") is a holding company the shares
of which are being traded on the OTCQB venture stage marketplace for early
stage and developing U.S. and international companies (OTCQB: SGBI).
Companies are current in their reporting and undergo an annual verification
and management certification process. Sangui shares also trade on the OTC
markets of Berlin and Hamburg-Hannover stock exchanges (symbol: SBH). Its
purpose is to provide financing and access to the capital markets for the
enterprises of the Sangui group. SanguiBioTech GmbH is a ninety percent
subsidiary of Sangui BioTech International, Inc.

For more information please contact:

Joachim Fleing
Phone: [phone]
Fax: [phone]
e-mail: [e-mail]



---------------------------------------------------------------------

06.11.2014 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


295497 06.11.2014